ask="7.57"
ask_size="1000"
average_daily_volume="932936"
bid="6.56"
bid_size="300"
book_value="0.05"
change="-0.02"
change_from_200_day_moving_average="1.39"
change_from_50_day_moving_average="0.39"
change_from_52_week_high="-1.00"
change_From_52_week_low="4.82"
change_in_percent="-0.30%"
close="6.56"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="42054000"
high="6.74"
high_52_weeks="7.56"
last_trade_date="2/17/2017"
last_trade_price="6.56"
last_trade_size="300"
last_trade_time="4:00pm"
low="6.33"
low_52_weeks="1.74"
market_capitalization="483.85M"
moving_average_200_day="5.17"
moving_average_50_day="6.17"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.10"
open="6.58"
pe_ratio="N/A"
peg_ratio="-0.36"
percent_change_from_200_day_moving_average="+26.78%"
percent_change_from_50_day_moving_average="+6.32%"
percent_change_from_52_week_high="-13.23%"
percent_change_from_52_week_low="+277.01%"
previous_close="6.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="121.85"
price_per_sales="22.09"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1364906"
weeks_range_52="1.74 - 7.56"
